PURPOSE: To determine whether a proximal (M1-segment) or distal (M2- and/or M3-segment) hyperattenuating middle cerebral artery (MCA) sign in patients with ischemic infarction in the territory of the MCA indicates a worse short-term prognosis than that in patients without a hyperattenuating MCA sign. MATERIALS AND METHODS: We retrospectively reviewed the records of 352 patients who were diagnosed with ischemic brain infarction in the territory of the MCA. Of these patients, 186 patients met our final criteria and were included in this study. Nonenhanced computed tomography (CT) was performed for the entire brain, with a 5-mm section thickness in all patients, within 24 hours after symptom onset. The presence and location of a hyperattenuating MCA sign was correlated with neurologic deficit at discharge from the hospital (ie, short-term prognosis) by using the chi(2) test to detect differences between patient groups. RESULTS: Patients with a hyperattenuating MCA sign at CT have a worse short-term prognosis than do patients without a hyperattenuating MCA sign (P <.05). Patients with a proximal hyperattenuating MCA sign have a significantly (P <.01) worse short-term prognosis than do patients with a distal hyperattenuating MCA sign. CONCLUSION: A proximal hyperattenuating MCA sign is a reliable predictor of poor short-term prognosis in patients who experience acute stroke.
PURPOSE: To determine whether a proximal (M1-segment) or distal (M2- and/or M3-segment) hyperattenuating middle cerebral artery (MCA) sign in patients with ischemic infarction in the territory of the MCA indicates a worse short-term prognosis than that in patients without a hyperattenuating MCA sign. MATERIALS AND METHODS: We retrospectively reviewed the records of 352 patients who were diagnosed with ischemic brain infarction in the territory of the MCA. Of these patients, 186 patients met our final criteria and were included in this study. Nonenhanced computed tomography (CT) was performed for the entire brain, with a 5-mm section thickness in all patients, within 24 hours after symptom onset. The presence and location of a hyperattenuating MCA sign was correlated with neurologic deficit at discharge from the hospital (ie, short-term prognosis) by using the chi(2) test to detect differences between patient groups. RESULTS:Patients with a hyperattenuating MCA sign at CT have a worse short-term prognosis than do patients without a hyperattenuating MCA sign (P <.05). Patients with a proximal hyperattenuating MCA sign have a significantly (P <.01) worse short-term prognosis than do patients with a distal hyperattenuating MCA sign. CONCLUSION: A proximal hyperattenuating MCA sign is a reliable predictor of poor short-term prognosis in patients who experience acute stroke.
Authors: Andrea Romano; Francesco Biraschi; Francesca Tavanti; Mario Beccia; Filomena Dilisi; Antonella Castrignanò; Giorgia Giuliani; Alberto Pierallini; Luigi Maria Fantozzi; Maurizia Rasura; Alessandro Bozzao Journal: Radiol Med Date: 2014-08-21 Impact factor: 3.469
Authors: Niko Sillanpaa; Jukka T Saarinen; Harri Rusanen; Jari Hakomaki; Arto Lahteela; Heikki Numminen; Irina Elovaara; Prasun Dastidar; Seppo Soimakallio Journal: Neuroradiology Date: 2011-09-09 Impact factor: 2.804
Authors: S M Mishra; J Dykeman; T T Sajobi; A Trivedi; M Almekhlafi; S I Sohn; S Bal; E Qazi; A Calleja; M Eesa; M Goyal; A M Demchuk; B K Menon Journal: AJNR Am J Neuroradiol Date: 2014-07-24 Impact factor: 3.825
Authors: Ludger Feyen; Patrick Haage; Patrick Freyhardt; Peter Schott; Marcus Katoh; Christian Blockhaus; Katharina Melber Journal: J Belg Soc Radiol Date: 2022-04-26 Impact factor: 1.894
Authors: Johanna Mucke; Markus Möhlenbruch; Philipp Kickingereder; Pascal J Kieslich; Philipp Bäumer; Christoph Gumbinger; Jan Purrucker; Sibu Mundiyanapurath; Heinz-Peter Schlemmer; Martin Bendszus; Alexander Radbruch Journal: PLoS One Date: 2015-04-07 Impact factor: 3.240